Gemphire Therapeutics Inc (GEMP):企業の財務・戦略的SWOT分析

◆英語タイトル:Gemphire Therapeutics Inc (GEMP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15904
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Gemphire Therapeutics Inc (GEMP) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Gemphire Therapeutics Inc (Gemphire), formerly Michigan Life Therapeutics LLC, is a clinical stage biopharmaceutical company that develops and commercializes therapies for patients with cardiometabolic disorders, including dyslipidemia and non-alcoholic steatohepatitis (NASH). Its lead product Gemcabene (CI-1027), which is licensed from Pfizer is an oral therapy that targets known lipid metabolic pathways, lowering levels of LDL-C, inflammation and triglycerides. The company is evaluating gemcabene in clinical trials to enhance the clearance of very low-density lipoproteins (VLDLs) and to and inhibit the production of fatty acids and cholesterol in the liver. Gemphire is headquartered in Livonia, Michigan, the US.

Gemphire Therapeutics Inc Key Recent Developments

Mar 15,2019 Gemphire Therapeutics reports fourth quarter and fiscal year 2018 financial results
Aug 13,2018 Gemphire Therapeutics reports second quarter 2018 financial results and provides corporate update
May 08,2018 Gemphire Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 03,2018 Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Gemphire Therapeutics Inc – Key Facts
Gemphire Therapeutics Inc – Key Employees
Gemphire Therapeutics Inc – Key Employee Biographies
Gemphire Therapeutics Inc – Major Products and Services
Gemphire Therapeutics Inc – History
Gemphire Therapeutics Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Gemphire Therapeutics Inc – Business Description
Gemphire Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Gemphire Therapeutics Inc – Strengths
Gemphire Therapeutics Inc – Weaknesses
Gemphire Therapeutics Inc – Opportunities
Gemphire Therapeutics Inc – Threats
Gemphire Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Gemphire Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 15, 2019: Gemphire Therapeutics reports fourth quarter and fiscal year 2018 financial results
Aug 13, 2018: Gemphire Therapeutics reports second quarter 2018 financial results and provides corporate update
May 08, 2018: Gemphire Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 03, 2018: Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer
Mar 15, 2018: Gemphire Therapeutics Announces Fourth Quarter And Fiscal Year 2017 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Gemphire Therapeutics Inc, Key Facts
Gemphire Therapeutics Inc, Key Employees
Gemphire Therapeutics Inc, Key Employee Biographies
Gemphire Therapeutics Inc, Major Products and Services
Gemphire Therapeutics Inc, History
Gemphire Therapeutics Inc, Key Competitors
Gemphire Therapeutics Inc, Ratios based on current share price
Gemphire Therapeutics Inc, Annual Ratios
Gemphire Therapeutics Inc, Annual Ratios (Cont...1)
Gemphire Therapeutics Inc, Interim Ratios
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Gemphire Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Gemphire Therapeutics Inc, Performance Chart (2014 - 2018)
Gemphire Therapeutics Inc, Ratio Charts
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Gemphire Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Gemphire Therapeutics Inc (GEMP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Paratek Pharmaceuticals Inc (PRTK):企業の財務・戦略的SWOT分析
    Paratek Pharmaceuticals Inc (PRTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • BlueScope Steel Ltd:企業のM&A・事業提携・投資動向
    BlueScope Steel Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BlueScope Steel Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Mizuho Financial Group, Inc.:企業の戦略・SWOT・財務分析
    SummaryMizuho Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Bell AG:企業概要・SWOT・財務分析
    Summary Canadean's "Bell AG : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, com …
  • Genocea Biosciences Inc (GNCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Genocea Biosciences Inc (Genocea), formerly GenoceaInc, is a cancer vaccines provider. The company discovers and develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. It provides Gen-009 and Gen-010 neoantigen cancer Vaccine pipeline.Genoceaatlas tech …
  • Continental Resources Inc (CLR):石油・ガス:M&Aディール及び事業提携情報
    Summary Continental Resources Inc (Continental Resources) is an oil and gas company involved in the distribution of fuel and related products and services. The company offerings include supply fulfillment and energy advisory services to commercial and industrial customers. It owns and operates Bakke …
  • Revolutions Medical Corporation (RMCP):(医療機器分野)企業M&A及び提携動向
    Summary Revolutions Medical Corporation (RMC) develops and distributes products and tools for the medical industry. It designs, develops and commercializes an auto-retractable safety syringe and other safety devices. RMC manufactures and sells RevVac safety syringe, which is designed to reduce accid …
  • Ray Sigorta A.S.:企業の戦略・SWOT・財務情報
    Ray Sigorta A.S. - Strategy, SWOT and Corporate Finance Report Summary Ray Sigorta A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Paramount Resources Ltd (POU):石油・ガス:M&Aディール及び事業提携情報
    Summary Paramount Resources Ltd (Paramount Resources) is an energy company that offers exploration, production, development, and marketing of oil and gas products. The company offers products such s crude oil, fuel oil, natural gas and natural gas liquids. It operates in three segments such as princ …
  • Zucara Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Zucara Therapeutics Inc (Zucara Therapeutics) is a pharmaceutical company that develops novel drug therapies to prevent hypoglycemia in people with diabetes. The company’s technology is used to prevent the dangerous low blood sugar by restoring the body’s ability to counter-regulate hypoglyc …
  • CHS Inc.:企業の戦略・SWOT・財務分析
    CHS Inc. - Strategy, SWOT and Corporate Finance Report Summary CHS Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Hangzhou Tigermed Consulting Co Ltd (300347):製薬・医療:M&Aディール及び事業提携情報
    Summary Hangzhou Tigermed Consulting Co Ltd (Hangzhou Tigermed) is a contract research organization that provides professional clinical trial services. The organization offers preclinical, clinical trials, registration and regulation; and other services. Its clinical trial services include monitorin …
  • Paradise Entertainment Limited (1180):企業の財務及び戦略的SWOT分析
    Summary Paradise Entertainment Limited (Paradise Entertainment) is an investment holding company that provides development, supply, leasing and sale of game machinery and equipment. The company offers casino management services. Its casinos offer various live table games such as baccarat, roulette a …
  • JSC Inter RAO:企業のM&A・提携・投資分析
    JSC Inter RAO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JSC Inter RAO Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • MLM Biologics Inc:製品パイプライン分析
    Summary MLM Biologics Inc (MLM Biologics) is a medical device company that provides optimum wound care management for patients and doctors. The company’s product includes bio-ConneKt Wound Matrix, a collagen-based wound dressing for wounds such as chronic vascular ulcers, draining wounds, partial an …
  • Japan Process Development Co. Ltd. (9651):企業財務及び戦略的SWOT分析
    Summary Japan Process Development Co. Ltd. (Japan Process) is a technology company that provides system integration, consulting and software development services. The company provides automotive-related system development, technology related to power-plant backbone systems, development of function c …
  • Aeterna Zentaris Inc.:企業のM&A・提携・投資分析
    Aeterna Zentaris Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aeterna Zentaris Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • BBA Aviation plc:企業の戦略・SWOT・財務情報
    BBA Aviation plc - Strategy, SWOT and Corporate Finance Report Summary BBA Aviation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Taekwang Industrial Co., Ltd. (003240):企業概要、財務及び戦略的SWOT分析
    Summary Taekwang Industrial Co., Ltd. (Taekwang) is a chemical company. The company manufacturers petrochemical, fiber and textile, and advanced materials. It offers products such as purified terephthalic acid, propylene, acrylonitrile, sodium cyanide, ammonium sulphate, acetonitrile and hydrogen pe …
  • Novan, Inc.(製薬・医療分野):企業M&A動向
    Summary Novan, Inc. (Novan) is a clinical-stage biotechnology company. It focuses on the development of nitric oxide therapies. The company by utilizing its NITRICIL technology customizes the macromolecular delivery of nitric oxide. It also undertakes the production of active pharmaceutical ingredie …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆